Browse our full range of services to find the right treatment for your goals
When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to get FDA approval since 2014 and immediately became the go-to weight-loss treatment
Each of these indication groups was compared with randomly selected control participants drawn from EMR data between 2021 and 2022
Side Effects of GLP-1 Medications The most common side effects of GLP-1 medications are nausea, vomiting, diarrhea, constipation, headaches, and fatigue, with nearly half of Wegovy users reporting nausea
Evidently, feeling tired is often associated with semaglutide medications
It was also approved on January 18, 2025, for its effects in reducing kidney disease and cardiovascular risk in diabetic adults